XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Preferred Stock [Member]
AOCI Attributable to Parent [Member]
Balance (in shares) at Dec. 31, 2020   1,280,207        
Balance at Dec. 31, 2020 $ 24,814,182 $ 1,280 $ 130,722,286 $ (105,909,384)    
Sale of common stock (in shares)   673,171        
Sale of common stock 31,094,302 $ 673 31,093,629 0    
Issuance of common stock upon exercise of warrants, net of issuance costs (in shares)   84,600        
Issuance of common stock upon exercise of warrants, net of issuance costs 2,201,450 $ 85 2,201,365 0    
Stock-based compensation expense 181,280 0 181,280 0    
Net loss (4,643,919) $ 0 0 (4,643,919)    
Unrealized loss on marketable securities 0          
Balance (in shares) at Mar. 31, 2021   2,037,978        
Balance at Mar. 31, 2021 53,647,295 $ 2,038 164,198,560 (110,553,303)    
Balance (in shares) at Dec. 31, 2021   2,038,185     0  
Balance at Dec. 31, 2021 34,911,467 $ 2,038 164,914,540 (130,005,111) $ 0 $ 0
Sale of common stock (in shares)   0     10,000  
Sale of common stock 5,000 $ 0 0 0 $ 5,000 0
Net loss (4,526,641) $ 0 0 (4,526,641) $ 0 0
Stock-based compensation expense and vesting of restricted stock units (in shares)   207     0  
Stock-based compensation expense and vesting of restricted stock units 278,131 $ 0 278,131 0 $ 0 0
Unrealized loss on marketable securities (49,658) $ 0 0 0 $ 0 (49,658)
Balance (in shares) at Mar. 31, 2022   2,038,392     10,000  
Balance at Mar. 31, 2022 $ 30,618,299 $ 2,038 $ 165,192,671 $ (134,531,752) $ 5,000 $ (49,658)